| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 30.0 MILLIGRAMS SODIUM TETRADECYL SULFATE ACTIVE INGREDIENT AND 0.02 MILLILITERS BENZYL ALCOHOL ACTIVE INGREDIENT AND 9.0 MILLIGRAMS SODIUM PHOSPHATE, DIBASIC ACTIVE INGREDIENT |
| ADMINISTRATION | INTRAVENOUS |
| FEATURES PROVIDED | STERILE |
| HAZARDOUS SUBSTANCES | ALCOHOL |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | SOTRADECOL 3% (SODIUM TETRADECYL SULFATE INJECTION), 2ML VIAL, 5 PER CARTON |
| PRIMARY CONTAINER CONTENT QUANTITY | 2.0 MILLILITERS |
| PRIMARY CONTAINER TYPE | VIAL |
| PROTECTIVE STORAGE FEATURE | CONTROLLED ROOM TEMPERATURE |
| SPECIAL FEATURES | SODIUM TETRADECYL SULFATE 3 PERCENT INJECTION (SOTRADECOL); 30MG/ML, 2ML VIALS, CARTON CONTAINING 5 VIALS; FOR INTRAVENOUS USE ONLY; STERILE AND NONPYROGENIC; STRENGTH: 3 PERCENT (30 MG/ML); VIAL FILL VOLUME: 2 ML; VIAL SIZE 3 ML; EACH ML CONTAINS SODIUM TETRADECYL SULFATE 30 MG, BENZYL ALCOHOL 0.02 ML AND DIBASIC SODIUM PHOSPHATE, ANHYDROUS 9.0 MG IN WATER FOR INJECTION; UNIT OF ISSUE IS A BOX CONTAINING 5 EACH (VIALS); STORE AT 20 TO 25 C (68 TO 77 F), (SEE USP CONTROLLED ROOM TEMPERATURE) |
| TOTAL PRIMARY CONTAINER QUANTITY | 5 |